IL-32 alpha, human recombinant protein
NK4, TAIF, TAIFa, TAIFb, TAIFc, TAIFd, IL-32β, IL-32α, IL-32delta, IL-32γ, Interleukin-32, IL-32, Na
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P24001 |
---|---|
Calculated MW | 14.9 kDa |
Gene ID | 9235 |
---|---|
Gene Symbol | IL32- α |
Other Names | NK4, TAIF, TAIFa, TAIFb, TAIFc, TAIFd, IL-32β, IL-32α, IL-32delta, IL-32γ, Interleukin-32, IL-32, Natural killer cells protein 4, Tumor necrosis factor α-inducing factor, IL-32a, IL32a, IL32, Interleukin-32 α. |
Gene Source | Human |
Source | E. coli |
Assay&Purity | SDS-PAGE; ≥97% |
Assay2&Purity2 | HPLC; |
Recombinant | Yes |
Results | In progress |
Target/Specificity | IL-32 alpha |
Application Notes | It is recommended to reconstitute the lyophilized product with sterile H₂O at a concentration of 0.1 mg/ml, which can be further diluted into other aqueous solutions. |
Format | Lyophilized protein |
Storage | -20°C; Lyophilized from 50 mM NaP, pH 7.5. |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Human IL-32 α is one of approximately 6 splice variants of a gene cloned from the human lung carcinoma stable transfectant, A549-Rβ. IL-32 α has been shown to induce IL-8, TNF-α, and MIP-2 production from human & mouse macrophage cell lines. It is up-regulated in activated T- & NK-cells, and IFN-g-treated epithelial cells. Human recombinant IL-32 α produced in E. coli is a 131 amino acid non-glycosylated polypeptide with a molecular mass of 14.9 kDa.
References
Dahl C.A.,et al.J. Immunol. 148:597-603(1992).
Kim S.-H.,et al.Immunity 22:131-142(2005).
Mao W.,et al.Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Oh J.H.,et al.Mamm. Genome 16:942-954(2005).

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.